Advertisement

Topics

FDA awards orphan status to new brain cancer vaccine

05:48 EDT 9 Aug 2017 | Pharmafile

The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the most common form of brain cancer and a condition which affects 14,000 new patients in the US every month.

read more

Original Article: FDA awards orphan status to new brain cancer vaccine

NEXT ARTICLE

More From BioPortfolio on "FDA awards orphan status to new brain cancer vaccine"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...